Skip to content
10-Q

Quarterly Report

OCATA THERAPEUTICS, INC.

0001019687-14-004157

← back to feed
Filed
Nov 10, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 4, 2014 34.39M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $723.01K
Stockholders Equity Q3 2014 · Dec 31, 2013 −$22.53M
Current Liabilities Q3 2014 · Sep 30, 2014 $6.66M
Current Liabilities Q3 2014 · Dec 31, 2013 $22.92M
Total Liabilities Q3 2014 · Sep 30, 2014 $8.52M
Total Liabilities Q3 2014 · Dec 31, 2013 $26.44M
Current Assets Q3 2014 · Sep 30, 2014 $8.35M
Current Assets Q3 2014 · Dec 31, 2013 $2.91M
Total Assets Q3 2014 · Sep 30, 2014 $9.25M
Total Assets Q3 2014 · Dec 31, 2013 $3.91M
Shares Diluted Q3 2014 · Sep 30, 2013 25.73M sh
Shares Diluted Q3 2014 · Sep 30, 2013 24.51M sh
Capex Q3 2014 · Sep 30, 2013 $586.09K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $5.45M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $7.24M
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.22
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.78
Eps Basic Q3 2014 · Sep 30, 2013 −$0.22
Eps Basic Q3 2014 · Sep 30, 2013 −$0.78
Sga Expense restated Q3 2014 · Sep 30, 2013 $3.22M
Sga Expense restated Q3 2014 · Sep 30, 2013 $9.17M
Rd Expense restated Q3 2014 · Sep 30, 2013 $3.06M
Rd Expense restated Q3 2014 · Sep 30, 2013 $8.67M
Net Income restated Q3 2014 · Sep 30, 2013 −$5.75M
Net Income restated Q3 2014 · Sep 30, 2013 −$19.15M
Operating Income restated Q3 2014 · Sep 30, 2013 −$6.26M
Operating Income restated Q3 2014 · Sep 30, 2013 −$17.72M
Gross Profit Q3 2014 · Sep 30, 2013 $23.86K
Gross Profit Q3 2014 · Sep 30, 2013 $118.69K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $15.61K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $66.83K